Wouter Bult
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 10%
Papers in
-
- Radiopharmaceutical Chemistry and Applications 8
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Co-authors
- J. Frank W. Nijsen (9 shared papers)Wim E. Hennink (5 shared papers)Chris Oerlemans (1 shared paper)Gerrit Storm (1 shared paper)Alfred D. van het Schip (8 shared papers)Maarten A. D. Vente (4 shared papers)Bernard A. Zonnenberg (3 shared papers)Hugo W. A. M. de Jong (3 shared papers)
- Journals
- Pharmaceutical Research (4 papers)PLoS ONE (2 papers)Journal of Critical Care (2 papers)The Lancet (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- NetherlandsDenmarkBelgium
In The Last Decade
Wouter Bult
25 papers receiving 1.3k citations
Wouter Bult's Hit Papers
Peers
Comparison fields: 5 of 96
- Biomaterials 611
- Drug Discovery 8
- Pharmaceutical Science 87
- Geriatrics and Gerontology 37
- Hepatology 90
Countries citing papers authored by Wouter Bult
This map shows the geographic impact of Wouter Bult's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Bult with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Bult more than expected).
Fields of papers citing papers by Wouter Bult
This network shows the impact of papers produced by Wouter Bult. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Bult. The network helps show where Wouter Bult may publish in the future.
Co-authors
The 25 scholars most cited alongside Wouter Bult, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release Hit paper breakdown → | 2010 | 829 |
| 2 | 2010 | 88 | |
| 3 | 2009 | 37 | |
| 4 | Microsphere radioembolization of liver malignancies: current developments. | 2009 | 35 |
| 5 | 2013 | 30 | |
| 6 | 2010 | 27 | |
| 7 | 2009 | 25 | |
| 8 | 2024 | 25 | |
| 9 | 2020 | 24 | |
| 10 | 2011 | 20 | |
| 11 | 2020 | 15 | |
| 12 | 2012 | 14 | |
| 13 | 2019 | 14 | |
| 14 | 2020 | 14 | |
| 15 | 2019 | 13 | |
| 16 | 2023 | 13 | |
| 17 | 2019 | 12 | |
| 18 | 2019 | 12 | |
| 19 | 2014 | 11 | |
| 20 | 2017 | 10 |
About Wouter Bult
Wouter Bult is a scholar working on Radiology, Nuclear Medicine and Imaging, Hepatology, Geriatrics and Gerontology, Internal Medicine and Emergency Medical Services, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Intravenous Infusion Technology and Safety (3 papers), Patient Safety and Medication Errors (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Biomaterials (611 citations), Drug Discovery (8 citations), Pharmaceutical Science (87 citations), Geriatrics and Gerontology (37 citations) and Hepatology (90 citations). Wouter Bult has collaborated with scholars based in Netherlands, Denmark and Belgium. Frequent co-authors include J. Frank W. Nijsen, Wim E. Hennink, Chris Oerlemans, Gerrit Storm, Alfred D. van het Schip, Maarten A. D. Vente, Bernard A. Zonnenberg, Hugo W. A. M. de Jong, Peter R. Seevinck and Chris J.G. Bakker. Their work appears in journals such as Pharmaceutical Research, PLoS ONE, Journal of Critical Care, The Lancet and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.